A phase II trial of neoadjuvant imatinib for large gastric GIST in Japan and Korea

Trial Profile

A phase II trial of neoadjuvant imatinib for large gastric GIST in Japan and Korea

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Imatinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network- Japan record.
    • 18 Dec 2013 Primary endpoint is changed from progression free survival to complete resection rate as per University Hospital Medical Information Network- Japan record.
    • 17 Dec 2013 Planned number of patients changed from 40 to 55 as reported by University Hospital Medical Information Network- Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top